Isotype can affect the fine specificity of an antibody for a polysaccharide antigen

Journal of Immunology

Volumn 169, Issue 3, 2002, Pages 1379-1386

  McLean, Gary R ^a   Torres, Marcela ^a   Elguezabal, Natalia ^a   Nakouzi, Antonio ^a   Casadevall, Arturo ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BACTERIAL POLYSACCHARIDE; GLUCURONOXYLOMANNAN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; IMMUNOGLOBULIN M; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 18B7; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; ARTICLE; BINDING COMPETITION; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN VARIABLE REGION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN QUATERNARY STRUCTURE; YEAST CELL;

EID: 0036681844     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.3.1379     Document Type: Article

References (33)

1. Role of heavy chain constant domains in antibody-antigen interaction: Apparent specificity differences among streptococcal IgG antibodies expressing identical variable region domains
2. Production and characterization of genetically engineered antibody molecules
3. Opsonophagocytic activity induced by chimeric antibodies of the four human IgG subclasses with or without help from complement
4. Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies
5. Application of engineered chimeric antibodies to the calibration of human antibody standards
6. Mouse/human chimeric monoclonal antibody in man: Kinetics and immune response
7. Characterization of a murine monoclonal antibody to Cryptocococcus neoformans polysaccharide that is a candidate for human therapeutic studies
8. Human and murine immunoglobulin expression vector cassettes
9. The use of chemiluminescence and the ELISA spot assay to identify and enumerate rare immunoglobulin switch variants
10. Molecular basis for immunoglobulin M specificity to epitopes in Cryptococcus neoformans that elicit protective and non-protective antibodies
11. Antibody interactions with the capsule of Cryptococcus neoformans
12. Molecular characterization of the antibody responses to Cryptococcus neoformans infection and glucuronoxylomannan-tetanus toxoid conjugate immunization
13. Determination of total and mercaptoethanol resistant antibody in the same serum sample
14. The different binding patterns of two IgM monoclonal antibodies to Cryptococcus neoformans serotype A and D strains correlates with serotype classification and differences in functional assays
15. Epitope location in the Cryptococcus neoformans capsule is a determinant of antibody efficacy
16. Protective and non-protective monoclonal antibodies to Cryptococcus neoformans originating from one B-cell
17. Molecular and idiotypic analysis of antibodies to Cryptococcus neoformans glucuronoxylomannan
18. Peptide libraries define the fine specificity of anti-polysaccharide antibodies to Cryptococcus neoformans
19. Molecular and idiotypic analysis of the antibody response to Cryptococcus neoformans glucuronoxylomannan-protein conjugate vaccine in autoimmune and non-autoimmune mice
20. Biological correlates of capsular (quellung) reactions of Cryptococcus neoformans
21. Conceptions of epitopes and paratopes and the ontological dynamics of immunological recognition
22. Defining epitopes: It's not as easy as it seems
23. A syngeneic idiotype is immunogenic when borne by IgM but tolerogenic when joined to IgG
24. Flexibility of human IgG3 subclasses
25. Comparison of the ability of human IgG3 hinge mutants, IgM, IgE, and IgA2 to form small immune complexes: A role for flexibility and geometry
26. In vitro and in vivo stability of a Cryptococcus neoformans glucuronoxylomannan epitope that elicits protective antibodies
27. Comparison of surface properties of human IgA, IgE, IgG, and IgM antibodies with identical and different specificities
28. The apparent monovalency of human IgG4 is due to bispecificity
29. Antibodies specific for the antigenic domain I of glycoprotein B (gpUL65) of human cytomegalovirus bind to different substructures
30. y: Reversal by humanization of monoclonal mouse antibody
31. Primary antibody-forming cells and secondary B cells are generated from separate precursor cell populations
32. H1 constant region domain modulate antigen binding affinity of antibodies?
33. Dimensions of antigen recognition and levels of immunological specificity